0001104659-21-050505.txt : 20210415 0001104659-21-050505.hdr.sgml : 20210415 20210415081633 ACCESSION NUMBER: 0001104659-21-050505 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20210415 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210415 DATE AS OF CHANGE: 20210415 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Teligent, Inc. CENTRAL INDEX KEY: 0000352998 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 010355758 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-08568 FILM NUMBER: 21827358 BUSINESS ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 BUSINESS PHONE: 856.697.1441 MAIL ADDRESS: STREET 1: 105 LINCOLN AVENUE CITY: BUENA STATE: NJ ZIP: 08310 FORMER COMPANY: FORMER CONFORMED NAME: IGI LABORATORIES, INC DATE OF NAME CHANGE: 20100408 FORMER COMPANY: FORMER CONFORMED NAME: IGI INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: IMMUNOGENETICS INC DATE OF NAME CHANGE: 19870814 8-K 1 tm2112973d1_8k.htm FORM 8-K
0000352998 false 0000352998 2021-04-15 2021-04-15 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 15, 2021

 

TELIGENT, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Delaware   001-08568   01-0355758
(State or other jurisdiction    (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification No.)

 

105 Lincoln Avenue

Buena, New Jersey 08310

(Address of Principal Executive Offices)(Zip Code)

 

Registrant’s telephone number, including area code: (856) 697-1441

 

Not applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, par value $0.01 per share TLGT The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company. ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 15, 2021, Teligent, Inc. (the “Company”) announced the appointment of Ernest R. De Paolantonio as Chief Financial Officer of the Company, to be effective immediately.

 

Mr. De Paolantonio, age 67, has over 40 years of varied financial and business experience in the pharmaceutical industry. Most recently, Mr.  Paolantonio served as Chief Financial Officer of Fortovia Therapeutics Inc., a privately held healthcare company providing support to cancer patients and their families. Prior to his position at Fortovia, Mr. De Paolantonio served as Chief Financial Officer, Secretary and Treasurer at BioDelivery Sciences International, Inc., a publicly-held specialty pharmaceutical company from 2013 to 2019. Prior to Mr. De Paolantonio’s position with BioDelivery Sciences, he served as the Chief Financial Officer of CorePharma LLC, a private specialty generic company, and held finance and controllers’ positions in roles of increasing responsibility at Colombia Laboratories. Mr. De Paolantonio received his Bachelor of Arts Degree from Lycoming College; his MBA in Finance at Saint Joseph’s University and is a licensed CPA.

 

The Company has entered into an employment agreement with Mr. De Paolantonio, effective April 15, 2021 (the “Employment Agreement”) in connection with his appointment as Chief Financial Officer. Pursuant to the terms of the Employment Agreement, Mr. De Paolantonio is employed at will, and either the Company or Mr. De Paolantonio may terminate the employment relationship for any reason, at any time. The Employment Agreement provides that Mr. De Paolantonio is entitled to a $335,000 annual base salary, subject to annual review by the Company. Following the end of each calendar year, Mr. De Paolantonio is eligible to receive an annual bonus calculated at 40% of his annual base salary. Mr. De Paolantonio’s target bonus percentage for the 2021 calendar year will be prorated. The Employment Agreement also includes the award of a one-time grant of (i) 195,000 restricted stock units (the “RSU Award”); and (ii) options to purchase 240,000 shares of Common Stock, with an exercise price equal to the fair market value of Teligent’s common stock on the effective date (the “Effective Date”) of Mr. De Paolantonio’s employment (the “Option”), with such grants intended to qualify as “inducement grants” under the rules of the Nasdaq Stock Market (the RSU Award and the Option collectively referred to as the “Awards”). The RSU Award will vest in four equal installments on each yearly anniversary of the Effective Date . The Option will vest on the third anniversary of the Effective Date based on the pro-rata achievement of certain performance milestones by the Company. The vesting of the Awards are subject to Mr. De Paolantonio’s continued employment and are subject to the terms and conditions of a restricted stock unit agreement and stock option agreement, respectively.

 

In the event that the Company terminates Mr. De Paolantonio’s employment without cause, Mr. De Paolantonio shall be entitled to (i) any unpaid base salary through the effective date of his termination, (ii) an amount per month equal to one-twelfth of Mr. De Paolantonio’s then adjusted base salary for a period of six months; (ii) any unpaid annual bonus from the prior fiscal year, (iv) an amount equal to Mr. De Paolantonio’s pro-rata portion of his annual bonus, (v) payment or reimbursement for COBRA premiums for six months and (vi) the vesting of a pro-rata portion of the equity awards granted to Mr. De Paolantonio equal to the quotient of the number of months between the Effective Date of the Employment Agreement and the date of termination divided by 36. In the event that Mr. De Paolantonio’s employment is terminated by the Company for cause or due to Mr. De Paolantonio’s death, disability or resignation, then the Company shall have no further obligation to Mr. De Paolantonio other than for any unpaid base salary through the date of termination. The Employment Agreement also contains certain standard provisions regarding confidentiality, assignment of intellectual property and non-solicitation.

 

The foregoing summary of the Employment Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Employment Agreement, which is attached as Exhibit 10.1 hereto and incorporated herein by reference.

 

Mr. De Paolantonio has no family relationships with any of the executive officers or directors of the Company. Except for the Employment Agreement, there are no arrangements or understandings between Mr. De Paolantonio and any other person pursuant to which he was elected as an officer of the Company. The Company is not aware of any transactions in which Mr. De Paolantonio has an interest that would require disclosure under Item 404(a) of Regulation S-K.

 

 

 

 

Item 9.01.Financial Statements and Exhibits.

 

(d)Exhibits.

 

Exhibit No.   Description
10.1   Employment Agreement effective April 15, 2021 between the Company and Ernest R. De Paolantonio.
99.1   Press release date April 15, 2021

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

TELIGENT, INC.

 

   
By:

/s/ Philip K. Yachmetz

    Name: Philip K. Yachmetz
    Title: Chief Legal Officer and Corporate Secretary

 

Date: April 15, 2021

 

 

 

EX-10.1 2 tm2112973d1_ex10-1.htm EXHIBIT 10.1

 

EXHIBIT 10.1

 

Execution Version

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (the "Agreement"), is dated as of the 8th day of April, 2021, by and between Teligent, Inc., having an address at 105 Lincoln Avenue, Buena, New Jersey 08310 (the “Company”) and Ernest R. DePaolantonio, having an address at 4 Krista Court, Mendham, New Jersey 07945-3134 (the “Executive”). The Company and the Executive are collectively referred to hereinafter as the “Parties”.

 

RECITALS:

 

WHEREAS, the Company desires to employ the Executive on the terms and subject to the conditions set forth herein, and Executive is willing to accept such employment of the terms and conditions; and

 

WHEREAS, by virtue of such employment, Executive will have access to Proprietary Information of the Company and its subsidiaries and affiliates (the “Teligent Companies”); and

 

WHEREAS, Executive acknowledges and agrees that the Teligent Companies have a reasonable, necessary and legitimate business interest in protecting their Proprietary Information, client accounts, relationships with prospective clients, goodwill and ongoing business, and that the terms and conditions set forth are reasonable and, necessary in order to protect these legitimate business interests.

 

NOW THEREFORE, in consideration of the representations, warranties, covenants, and agreements contained herein, and for other good and valuable consideration, the receipt and adequacy of which are conclusively acknowledged, the Parties, intending to become legally bound, agree as follows:

 

AGREEMENT

 

1.DEFINITIONS

 

1.1. Specific Definitions. Capitalized terms not defined elsewhere herein shall have the following meanings ascribed to them:

 

“Person” means an individual, a partnership, a corporation, an association, a joint stock company, a trust, a joint venture, an unincorporated organization, a limited liability company, or a governmental entity (or any department, agency, or political subdivision thereof).

 

 

 

 

2.POSITION, RESPONSIBILITIES AND TERM

 

2.1. Executive’s Position. On the terms and subject to the conditions set forth in this Agreement, the Company shall employ Executive to serve as an officer of the Company and as Chief Financial Officer of the Company. The Executive shall report directly to the Company’s Chief Executive Officer and shall perform such services in the Company’s offices in Buena and Metro Park (Iselin), New Jersey or such other location or locations as the Executive and the Board of Directors (the “Board”) shall agree; provided, however, that Executive will be required to travel from time to time for business purposes.

 

2.2. Executive’s Responsibilities. The Executive shall perform all duties customarily attendant to the position and shall perform such services and duties commensurate with such position as may from time to time be reasonably prescribed by the Board.

 

2.3. No Conflicts of Interest. Executive further agrees that throughout the period of his employment hereunder, he will not perform any activities or services, or accept such other employment which would be inconsistent with this Agreement, the employment relationship between the Parties, or would interfere with or present a conflict of interest concerning Executive's employment with the Company; provided, that Executive shall be permitted to serve on the boards of directors of such other companies not in competition with the Company as the Board shall approve in writing and that Executive may make personal investments and may act as a director and engage in other activities for any charitable, educational, or other nonprofit institution, as long as such investments and activities do not materially interfere with the performance of Executive’s duties hereunder. Executive agrees to adhere to and comply with any and all business practices and requirements of ethical conduct set forth in writing from time to time by the Company in its employee manual or similar publication.

 

2.4. Term. This Agreement shall become effective on April 15, 2021 (the “Effective Date”) and will govern Executive's employment by the Company until that employment ceases (such period of Executive's employment is herein referred to as the “Term”).

 

3.ACCEPTANCE

 

Executive hereby accepts such employment and agrees that throughout the Term, Executive will devote his full business time, attention, knowledge and skills faithfully, diligently and to the best of his ability, in the furtherance of the business of the Teligent Companies.

 

 

 

 

4.COMPENSATION

 

4.1. Base Salary. The Executive shall receive an initial annual salary of Three Hundred Thirty-Five Thousand Dollars ($335,000.00) (the “Base Salary”) paid in accordance with the Company's payroll practices, as in effect from time to time. The Base Salary shall be reviewed on an annual basis by the Company.

 

4.2. Benefits. In addition to such compensation, Executive shall be entitled to the benefits which are afforded generally, from time to time to similarly situated executive employees of the Teligent Companies. Notwithstanding the foregoing, nothing contained in this Agreement shall require the Teligent Companies to establish, maintain or continue any of the group benefits plans already in existence or hereafter adopted for the employees of the Teligent Companies, or restrict the right of the Teligent Companies to amend, modify or terminate such group benefit plans in a manner which does not discriminate against Executive as compared to other executive employees of Teligent Companies.

 

4.3. Paid Time Off. Executive shall be entitled to 20 business days of paid time off (consisting of vacation and personal days), and shall be entitled to sick days and holidays as are provided in general to similarly situated employees of the Teligent Companies, in accordance with usual practices and procedures, prorated for Executive’s first year of employment. Paid time off shall stop accruing once Executive has accumulated and not used the number of days to which he is entitled to in a year.

 

4.4. Annual Performance Bonuses.

 

(a) The Executive shall be eligible to receive an annual performance bonus (the “Annual Bonus”) for each calendar year during the Term (each a “Fiscal Year”), which shall be paid in cash not later than 75 days after the end of such Fiscal Year; provided, however, that the Executive must be employed by the Company on December 31 of a Fiscal Year in order to be eligible for an Annual Bonus under this Section 4.4 for such Fiscal Year.

 

(b) The Executive's target Annual Bonus will be Forty Percent (40%) of Executive’s Base Salary then in effect for each Fiscal Year (the “Target Bonus”). The Annual Bonus with respect to the 2021 Fiscal Year shall be pro-rated based on the partial year of employment. The actual amount of the Annual Bonus, if any, will be determined by the Board and/or the Compensation Committee of the Board (the “Committee”), in their sole discretion, with reference to the Executive's and the Company’s fulfillment of performance goals established by the Committee with respect to the applicable Fiscal Year, provided, however with respect to the 2021 Fiscal Year the actual amount of the Annual Bonus shall be calculated using a factor no less than that used to calculate the Annual Bonus of similarly situated executive employees of the Teligent Companies.

 

 

 

 

4.5. Grants of Equity Awards.

 

(a) Awards. As soon as practicable following the Effective Date of this Agreement and subject to the approval of the Board, Executive will receive the following equity grants: (i) 195,000 restricted stock units (the “RSU Award”); and (ii) options to purchase 240,000 shares of the Common Stock having an exercise price shall be equal to the fair market value of the Company’s Common Stock on the grant date (the “Option”) (together the RSU Award and Option may be referred to as the “Awards”). In addition, the Executive will be eligible for annual refresh and other equity awards at the Board’s discretion generally in line with those afforded, from time to time, to similarly situated executive employees of the Company. The Awards are intended to qualify as an “inducement grant” under the rules of the Nasdaq Stock Market. The Awards shall be subject to the terms of award agreements in forms to be provided by the Company.

 

(b) Vesting. Except as otherwise set forth in Section 8 hereof, subject to the Executive’s continued employment with the Company (i) the RSU Award shall vest twenty-five percent (25%) on each of the first four (4) anniversaries of the grant date and (ii) the Option shall vest on the third (3rd) anniversary based on the pro-rata achievement of the following performance milestones by the Company (A) the resolution of the November 2019 FDA Warning Letter, (B) FDA approval of the Company’s new sterile manufacturing facility, and (C) Launch by the Company or a customer of the Company of the first sterile product manufactured in the new sterile manufacturing facility (ie: one-third of the Options eligible to vest with achievement of each performance metric).

 

(c) Accelerated Vesting. Notwithstanding the foregoing, immediately prior to a Change in Control (as defined in the award agreements), any portion of the Awards that is not vested will become vested on the Change in Control provided the Executive remains in continuous service with the Company through the consummation of that Change in Control.

 

5.EXPENSES

 

The Company shall reimburse Executive, in accordance with Company policy, for all expenses reasonably and properly incurred by Executive in connection with the performance of Executive's duties hereunder and the conduct of the business of the Company, upon the submission to the Company (or its designee) of appropriate vouchers therefor. Company shall also reimburse Executive for all fees and expenses associated with maintaining Executive’s licenses, membership in a reasonable number of professional organizations selected by Executive or associated with attendance at a reasonable number of professional continuing education and/or industry conferences, or seminars selected by Executive in an amount not to exceed One Thousand Dollars ($1,000.00).

 

 

 

 

6.CONFIDENTIAL INFORMATION AND PROPERTY

 

6.1. Confidentiality. The Executive recognizes and acknowledges that the Proprietary Information (as defined below) is a valuable, special and unique asset of the business of the Teligent Companies. As a result, both during the Term and thereafter, the Executive will not, without the prior written consent of the Company, for any reason divulge to any third-party or use for his own benefit, or for any purpose other than the exclusive benefit of the Teligent Companies, any Proprietary Information. Notwithstanding the foregoing, if the Executive is compelled to disclose Proprietary Information by court order or other legal or regulatory process, to the extent permitted by applicable law, he shall promptly so notify the Company so that it may seek a protective order or other assurance that confidential treatment of such Proprietary Information shall be afforded, and the Executive shall reasonably cooperate with the Teligent Companies in connection therewith. If the Executive is so obligated by court order or other legal process to disclose Proprietary Information it will disclose only the minimum amount of such Proprietary Information as is necessary for the Executive to comply with such court order or other legal process.

 

6.2. Property of the Company.

 

(a) Proprietary Information. All right, title and interest in and to Proprietary Information will be and remain the sole and exclusive property of the Teligent Companies. The Executive will not remove from the offices or premises of the Teligent Companies any documents, records, notebooks, files, correspondence, reports, memoranda or similar materials of or containing Proprietary Information, or other materials or property of any kind belonging to the Teligent Companies unless necessary or appropriate in the performance of his duties to the Teligent Companies. If the Executive removes such materials or property in the performance of his duties, he will return such materials or property promptly after the removal has served its purpose. The Executive will not make, retain, remove and/or distribute any copies of any such materials or property, or divulge to any third person the nature of and/or contents of such materials or property, except to the extent necessary to satisfy contractual obligations of the Teligent Companies or to perform his duties on behalf of the Teligent Companies. Upon termination of the Executive's employment with the Company, he will leave with the Teligent Companies or promptly return to the Teligent Companies all originals and copies of such materials or property then in his possession.

 

 

 

 

(b) Intellectual Property. The Executive agrees that all the Intellectual Property (as defined below) will be considered “works made for hire” as that term is defined in Section 101 of the Copyright Act (17 U.S.C. § 101) and that all right, title and interest in such Intellectual Property will be the sole and exclusive property of the Teligent Companies. To the extent that any of the Intellectual Property may not by law be considered a work made for hire, or to the extent that, notwithstanding the foregoing, the Executive retains any interest in the Intellectual Property, the Executive hereby irrevocably assigns and transfers to the Teligent Companies any and all right, title, or interest that the Executive may now or in the future have in the Intellectual Property under patent, copyright, trade secret, trademark or other law, in perpetuity or for the longest period otherwise permitted by law, without the necessity of further consideration. The Teligent Companies will be entitled to obtain and hold in its own name all copyrights, patents, trade secrets, trademarks and other similar registrations with respect to such Intellectual Property. The Executive further agrees to execute any and all documents and provide any further cooperation or assistance reasonably required by the Company, at the Company's expense, to perfect, maintain or otherwise protect its rights in the Intellectual Property. If the Teligent Companies, as applicable, are unable after reasonable efforts to secure the Executive's signature, cooperation or assistance in accordance with the preceding sentence, whether because of the Executive's incapacity or any other reason whatsoever, the Executive hereby designates and appoints the Company, the appropriate affiliate, or their respective designee as the Executive's agent and attorney-in-fact, to act on his behalf, to execute and file documents and to do all other lawfully permitted acts necessary or desirable to perfect, maintain or otherwise protect the Teligent Companies' rights in the Intellectual Property. The Executive acknowledges and agrees that such appointment is coupled with an interest and is therefore irrevocable.

 

For purposes of this Agreement, “Intellectual Property” means (a) all inventions (whether patentable or unpatentable and whether or not reduced to practice), all improvements thereto, and all patents and patent applications claiming such inventions, (b) all trademarks, service marks, trade dress, logos, trade names, fictitious names, brand names, brand marks and corporate names, together with all translations, adaptations, derivations, and combinations thereof and including all goodwill associated therewith, and all applications, registrations, and renewals in connection therewith, (c) all copyrightable works, all copyrights, and all applications, registrations, and renewals in connection therewith, (d) all mask works and all applications, registrations, and renewals in connection therewith, (e) all trade secrets (including research and development, know-how, formulas, compositions, manufacturing and production processes and techniques, methodologies, technical data, designs, drawings and specifications), (f) all computer software (including data, source and object codes and related documentation), (g) all other proprietary rights, (h) all copies and tangible embodiments thereof (in whatever form or medium), or (i) similar intangible personal property which have been or are developed or created in whole or in part by the Executive (1) at any time and at any place while the Executive is employed by Company and which, in the case of any or all of the foregoing, are related to and used in connection with the business of the Teligent Companies, or (2) as a result of tasks assigned to the Executive by the Teligent Companies.

 

 

 

 

For purposes of this Agreement, “Proprietary Information” means any and all proprietary information developed or acquired by the Teligent Companies that has not been specifically authorized to be disclosed. Such Proprietary Information shall include, but shall not be limited to, the following items and information relating to the following items: (a) all intellectual property and confidential or proprietary knowledge, information or rights of the Company (including, without limitation, the Intellectual Property, trade secrets, books and records, know-how, inventions, discoveries, processes and systems, as well as any data and records pertaining thereto), (b) computer codes and instructions, processing systems and techniques, inputs and outputs (regardless of the media on which stored or located) and hardware and software configurations, designs, architecture and interfaces, (c) business research, studies, procedures and costs, (d) financial data, (e) distribution methods, (f) marketing data, methods, plans and efforts, (g) the identities of actual and prospective customers and suppliers, (h) the terms of contracts and agreements with, the needs and requirements of, and the Teligent Companies' course of dealing with, actual or prospective customers and suppliers, (i) personnel information, (i) customer and vendor credit information, and (k) information received from third parties subject to obligations of non-disclosure or non-use. Failure by the Teligent Companies to mark any of the Proprietary Information as confidential or proprietary shall not affect its status as Proprietary Information.

 

7.NON-SOLICITATION, NON-COMPETITION

 

Executive agrees that (a) during the Term and for six (6) months following the end of the Term, executive will not, directly or indirectly, on behalf of himself of any Person own any interest in, operate, join, control or participate as a partner, shareholder, member, director, manager, officer, or agent of, enter into the employment of, act as a consultant to, or perform any services for any entity that is in competition with the Company; or (b) during the Term and for twelve (12) months following the end of the Term, Executive will not, directly or indirectly, on behalf of himself or any Person (i) solicit business from any Person, or interfere with any relationship of the Company with any Person, which is then, or was during the twelve month period preceding such prohibited activity, a client of the Company, or (ii) solicit the employment of, or hire, any employee of the Company or otherwise induce any such employee to leave the Company's employment or to breach an employment agreement therewith.

 

 

 

 

8.TERMINATION

 

Either party may terminate the Executive's employment at any time for any reason, provided that the Executive shall provide thirty (30) days advance written notice of any resignation by the Executive. Upon cessation of his employment with the Company, the Executive will be entitled only to such compensation and benefits as described in this Section 8.

 

8.1. Termination by the Company Without Cause. In the event the Company terminates the Executive’s employment without Cause (and other than due to his death or Disability), the Company shall pay Executive (i) his unpaid Base Salary through the effective date of termination, (ii) any earned Annual Bonus for the prior Fiscal Year which is unpaid at the time of termination and (iii) any business expenses remaining unpaid on the effective date of the termination for which Executive is entitled to be reimbursed under Section 5 of this Agreement (the “Accrued Obligations”). In addition, and subject to Executive’s execution of the Release as described in Section 8.4, the Company shall (i) pay Executive an amount per month equal to one-twelfth of his then adjusted Base Salary for the period commencing on the date following the date of termination and ending on the date which is six (6) months following the effective date of termination; (ii) pay Executive an amount equal to a pro-rata portion of the Annual Bonus that would otherwise have been payable to Executive for the Fiscal Year in which the termination occurs, determined in the same manner and payable at the first practicable payroll date following the date the Release is effective, with such pro-rata portion to be determined based on the number of months (and any fraction thereof) Executive is employed during the Fiscal Year in which termination occurs, relative to 12 months; (iii) pay or reimburse Executive for COBRA premiums for six (6) months following termination or such earlier date Executive becomes covered under the employee benefit plans of a subsequent employer; and (iv) to the extent then unvested, cause to become vested a pro-rata portion of the Awards equal to the quotient of the number of full months that have transpired between the Effective Date and date of termination, divided by 36. All obligations described clauses (i) through (iii) in this Section 8.1 shall immediately terminate upon a court of competent jurisdiction’s determination that Executive has breached the provisions of Section 6 or 7 hereof.

 

For the purpose of this Agreement, “Cause” shall mean (i) commission of a willful and material act of dishonesty in the course of Executive's duties hereunder, (ii) conviction by a court of competent jurisdiction of a crime constituting a felony or conviction in respect of any act involving fraud, dishonesty or moral turpitude, (iii) Executive's performance under the influence of controlled substances, or continued habitual intoxication, during working hours, after the Company shall have provided written notice to Executive and given Executive 30 days within which to commence rehabilitation with respect thereto, and Executive shall have failed to commence such rehabilitation or continued to perform under the influence after such rehabilitation, (iv) frequent or extended, and unjustifiable (not as a result of incapacity or disability) absenteeism which shall not have been cured within 30 days after the Company shall have advised Executive in writing of its intention to terminate Executive's employment in accordance with the provisions of this Section 8.1, in the event such condition shall not have been cured, (v) Executive's personal, willful and continuing misconduct or refusal to perform duties and responsibilities described in Section 2 above, or to carry out directives of the Board which, if capable of being cured, shall not have been cured within 60 days after the Company shall have advised Executive in writing of its intention to terminate Executive's employment in accordance with the provision of this Section 8.1 or (vi) material non-compliance with the terms of this Agreement, including but not limited to any breach of Section 6 or Section 7 of this Agreement.

 

 

 

 

8.2. Other Terminations. If the Executive’s employment with the Company is terminated (a) by the Company for Cause, (b) as a result of the Executive's death, (c) as a result of the Executive's Disability, or (d) as a result of Executive’s resignation for any reason, then the Company's obligation to the Executive will be limited solely to the payment of the Accrued Obligations. All compensation and benefits will cease at the time of such termination and, except as otherwise required by applicable law, the Company will have no further liability or obligation by reason of such termination. The foregoing will not be construed to limit the Executive’s right to payment or reimbursement for claims incurred prior to the date of such termination under any insurance contract funding an employee benefit plan, policy or arrangement of the Company in accordance with the terms of such insurance contract.

 

For the purpose of this Agreement, a “Disability” shall be deemed to have occurred (i) when Executive has become eligible for disability benefits under the Company's long-term group disability policy, if any, or, if no policy is then in effect, (ii) when such incapacity or disability shall have existed for either (A) one continuous period of six months or (B) a total of seven months out of any twelve consecutive months.

 

8.3. Miscellaneous Termination Provisions.

 

Executive, upon termination or expiration of employment for any reason, hereby irrevocably promises to:

 

(a)     Return all property of the Teligent Companies in his possession or within his custody and control wherever located immediately upon such termination.

 

(b)     Participate in an exit interview with a designated person or persons of Company if requested by Company.

 

(c)     Subject to obligations under applicable laws and regulations, not publicly make any statements or comments that disparage the reputation of any of the Teligent Companies or their senior officers or directors.

 

8.4. Release. Notwithstanding any other provision of this Agreement, the payments and benefits described in Section 8.l (i) through (iii) are conditioned on Executive's execution and delivery to the Company, within 60 days following his cessation of employment, of a form of separation agreement containing a general release of claims against the Company and its affiliates in a form to be provided by the Company (the “Release”). If the 60-day period described in the previous sentence begins in one taxable year and ends in a second taxable year and if the cash payments and benefits described in Section 8.1 exceed the limitations applicable to a “separation pay plan” under Treas. Reg. § 1.409A-l(b)(9)(iii), such payments and other rights shall not commence until the second taxable year.

 

 

 

 

8.5. Section 409A. The intent of the Parties is that payments and benefits under this Agreement comply with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), to the extent subject thereto, and accordingly, to the maximum extent permitted, this Agreement shall be interpreted and administered to be in compliance therewith. For purposes of this Agreement, all references to ''termination of employment” and correlative phrases shall be construed to require a “separation from service” (as defined in Treas. Reg. §1.409A-l(h) after giving effect to the presumptions contained therein), and the term “specified employee” means an individual determined by the Company to be a specified employee under Treas. Reg. § 1.409A-l(i). If the termination giving rise to the payments described in Section 8.1 is not a “separation from service”, then the amounts otherwise payable pursuant to that section will instead be deferred without interest and will not be paid until Executive experiences a “separation from service”. If at the time of the Executive's termination of employment, the Executive is a “specified employee,” as defined below, any and all amounts payable under Section 8 on account of such separation from service that constitute deferred compensation and would (but for this provision) be payable within six (6) months following the date of termination, shall instead be paid on the next business day following the expiration of such six (6) month period or, if earlier, upon the Executive's death; except (A) to the extent of amounts that do not constitute a deferral of compensation within the meaning of Treas. Reg.§ l.409A-l(b) (including without limitation by reason of the safe harbor set forth in Treas. Reg. § 1.409A- l(b)(9)(iii), as determined by the Company in its reasonable good faith discretion); (B) benefits that qualify as excepted welfare benefits pursuant to Treas. Reg.§ 1.409A-l(a)(5); or (C) other amounts or benefits that are not subject to the requirements of Section 409A. To the maximum extent permitted under Section 409A of the Code and its corresponding regulations, the cash severance benefits payable under this Agreement are intended to meet the requirements of the short-term deferral exemption under Section 409A of the Code and the “separation pay exception” under Treas. Reg.§ l.409A-l(b)(9)(iii). For purposes of the application of Treas. Reg. § l .409A-l(b)(4) (or any successor provision), each payment in a series of payments will be deemed a separate payment. To the extent required to avoid an accelerated or additional tax under Section 409A of the Code, amounts reimbursable to the Executive under this Agreement shall be paid to the Executive on or before the last day of the year following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in kind benefits provided to the Executive) during one year may not affect amounts reimbursable or provided in any subsequent year.

 

 

 

 

9.REMEDIES

 

Executive acknowledges that the services to be rendered by him are of a special, unique and extraordinary character and that it would be extremely difficult or impracticable to replace such services, that the material provisions of this Agreement are of crucial importance to the Company and that any damage caused by the breach of Sections 6 or 7 of this Agreement would result in irreparable harm to the business of the Company for which money damages alone would not be adequate compensation. Accordingly, Executive agrees that if he violates Sections 6 or 7 of this Agreement, the Company shall, in addition to any other rights or remedies of the Company available at law, be entitled to equitable relief in any court of competent jurisdiction, including, without limitation, temporary injunction and permanent injunction.

 

10.WITHHOLDING

 

Each payment to Executive under this Agreement shall be reduced by any amounts required to be withheld by the Company from time to time under applicable laws and regulations then in effect.

 

11.EXECUTIVE’S REPRESENTATIONS AND WARRANTIES

 

11.1. General. Executive represents and warrants to the Company that the execution of this Agreement and the performance of his duties as contemplated hereunder do not conflict with any other agreement, law, rule, regulation, or court order by which he is bound.

 

11.2. No Impairment. Executive represents and warrants that he is not subject to any agreement or contract that would preclude or impair, in any way, his ability to carry out his duties under this Agreement for the Company.

 

11.3. No Confidential Information. Executive has not removed from any prior employer any confidential information.

 

11.4. No Restrictive Agreements. Executive represents and warrants that, Executive has not heretofore entered into, has not been and is currently not subject to the provisions of, any employment contract, sales and purchase agreement or other agreement (whether oral or written) of any nature whatsoever with any other organization, individual or business entity, which prevents or restricts Executive from entering into this Agreement or performing his duties hereunder, other than such contracts or agreements as Executive has heretofore disclosed to Company in writing.

 

 

 

 

12.INTELLECTUAL PROPERTY AND OWNERSHIP OF BUSINESS

 

12.1. Ownership of Records. Executive agrees that all papers, documents, records, business accounts, generated by Executive during the conduct of such business or given to

 

Executive during and in the course of his employment with Company is the exclusive property of the Company and shall remain with the Company upon Executive's termination.

 

12.2. Intellectual Property. Executive further agrees to assign without further consideration all intellectual property, including but not limited to inventions, discoveries or any material produced by him during the course of his employment hereunder (including modifications or refinements of such materials) to the Company in their entirety. Such assignment and transfer is a complete and total assignment and transfer of any right Executive may have in such intellectual property and includes any patent, copyright, trade or service mark or the right to obtain any such patent, copyright, trade or service mark, and any trade secret rights in such material. This provision does not entitle Executive to any additional compensation, with such compensation, if any, being entirely within the discretion of Company.

 

13.ENTIRE AGREEMENT; NO AMENDMENT

 

No agreements or representations, oral or otherwise, express or implied, have been made by either Party, with respect to Executive's employment by any Teligent Company, that are not set forth expressly in this Employment Agreement. This Agreement supersedes and cancels any other prior agreement relating to Executive's employment by any Teligent Company, except that Executive shall remain liable for any breaches of any provisions relating to restrictive covenants (including non-solicitation, non-compete, non-hire) and confidentiality contained in any such prior agreements. No amendment or modification of this Agreement shall be valid or binding unless made in writing and signed by the Party against whom enforcement thereof is sought.

 

14.NOTICES

 

All notices, demands and requests of any kind which either Party may be required or may desire to serve upon the other Party hereto in connection with this Agreement shall be delivered only by courier or other means of personal service, which provides written verification of receipt, or by registered or certified mail return receipt requested (each, a “Notice”). Any such Notice delivered by registered or certified mail shall be deposited in the United States mail with postage thereon fully prepaid or ifby courier then deposited with the courier. All Notices shall be addressed to the Parties to be served as follows:

 

(a) If to the Company, at the Company's address set forth on the first page hereof.

 

 

 

 

(b) If to Executive, at Executive's address set forth on the first page hereof.

 

Either of the Parties hereto may at any time and from time to time change the address to which notice shall be sent hereunder by notice to the other Party given under this Section. All such notices, requests, demands, and other communications shall be effective when received at the respective address set forth above or as then in effect pursuant to any such change.

 

15.WAIVERS

 

No waiver of any default or breach of this Agreement shall be deemed a continuing waiver or a waiver of any other breach or default.

 

16.GOVERNING LAW

 

THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW.

 

17.SEVERABILITY

 

The provisions of this Agreement are intended to be interpreted in a manner which makes them valid, legal, and enforceable, in the event any provision of this Agreement is found to be partially or wholly invalid, illegal or unenforceable, such provision shall be modified or restricted to the extent and in the manner necessary to render it valid, legal, and enforceable, it is expressly understood and agreed between Executive and the Company that such modification or restriction may be accomplished by mutual accord between the Parties or, alternatively, by disposition of a court of law. If such provision cannot under any circumstances be so modified or restricted, it shall be excised from this Agreement without affecting the validity, legality or enforceability of any of the remaining provisions.

 

18.ASSIGNMENT

 

Executive may not assign any rights (other than the right to receive income hereunder) under this Agreement without the prior written consent of the Company. This Agreement may be assigned without the consent of Executive to any Teligent Company or any successor to all or substantially all of the assets of the Company and this Agreement shall be binding upon and shall inure to the benefit of the assignee hereof.

 

 

 

 

19.MISCELLANEOUS

 

For the avoidance of doubt, the provisions of sections 6, 7, 8, 16, 20 and any other ongoing duties of the parties hereto shall survive termination or expiration of this Agreement.

 

20.INDEMNIFICATION

 

The Company will indemnify Executive in accordance with the terms of the Company's articles of incorporation and/or by-laws. Executive shall be covered under any directors' and officers’ liability insurance policy then in effect for the Company or any of its affiliates as to which Executive is serving as a director or officer, which directors’ and officers’ policy shall include employed lawyers coverage in normal and customary amounts.

 

21.COUNTERPARTS

 

This Agreement may be executed in one or more counterparts and by different parties hereto in separate counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument.

 

Signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that all signature pages are physically attached to the same document.

 

22.HEADINGS

 

The headings of the several sections and subsections of this Agreement are inserted for convenience only and shall not in any way affect the meaning or construction of any provision of this Agreement.

 

23.CONSTRUCTION OF AGREEMENT

 

All Parties agree that this Agreement shall be construed in such a manner so as not to favor one party or the other regardless of which party has drafted this Agreement.

 

[Remainder of Page Intentionally Left Blank]

 

 

 

 

IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

  TELIGENT, INC.
   
  By: /s/ Timothy B. Sawyer
       Timothy B. Sawyer
    President & Chief Executive Officer

 

 

  EXECUTIVE
   
  By: /s/ Ernest R. De Paolantonio
       Ernest R. De Paolantonio

 

 

 

EX-99.1 3 tm2112973d1_ex99-1.htm EXHIBIT 99.1

 

EXHIBIT 99.1

 

 

 

Teligent Announces Hiring of Chief Financial Officer

 

Buena, N.J., April 15, 2021 (GLOBENEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, today announced the hiring and appointment of Ernest R. De Paolantonio as Chief Financial Officer of the Company, effective April 15, 2021.

 

Timothy B. Sawyer, President and CEO of the Company, commented, “We are very pleased that Ernie has agreed to join our Teligent team. Over the last several months, we have made key additions to our leadership team, and the appointment of Ernie to the CFO position reflects our commitment to bring in highly talented and experienced individuals who have a strong track record of success. Ernie’s extensive experience as a chief financial officer with pharmaceutical and healthcare companies will be an excellent addition to our team.”

 

Mr. De Paolantonio has over 40 years of financial and business experience in the pharmaceutical industry. Most recently, Mr. De Paolantonio served as Chief Financial Officer of Fortovia Therapeutics Inc., a privately held healthcare company providing support to cancer patients and their families. Prior to his position at Fortovia, he served as Chief Financial Officer, Secretary and Treasurer at BioDelivery Sciences International, Inc., a publicly-held specialty pharmaceutical company from 2013 to 2019. Prior to his position with BioDelivery Sciences, he served as the Chief Financial Officer of CorePharma LLC, a private specialty generic company, and held finance and controllers’ positions in roles of increasing responsibility at Colombia Laboratories. Mr. De Paolantonio received his Bachelor of Arts Degree from Lycoming College; his MBA in Finance at Saint Joseph’s University and is a licensed CPA.

 

Inducement Award

 

In connection with the hiring of Mr. De Paolantonio, in addition to other compensation disclosed in Teligent’s Current Report on Form 8-K, Teligent’s Board of Directors authorized the grant to Mr. De Paolantonio of (i) 195,000 restricted stock units; and (ii) a non-qualified stock option to purchase 240,000 shares of Common Stock. The awards are an inducement material to Mr. De Paolantonio’s entering into employment with Teligent in accordance with Nasdaq Listing Rule 5635(c)(4). The option has a ten-year term and an exercise price equal to the fair market value of Teligent’s common stock on the effective date of Mr. De Paolantonio’s employment. The restricted stock unit award will vest in four equal installments on each yearly anniversary of the effective date of Mr. De Paolantonio’s employment and the option will vest on the third anniversary of the effective date based on the pro-rata achievement of certain performance milestones by the Company. The vesting of the awards are subject to Mr. De Paolantonio’s continued employment and are subject to the terms and conditions of a restricted stock unit agreement and stock option agreement, respectively.

 

 

 

 

Forward-Looking Statements

 

This press release includes “forward-looking statements” that are intended to qualify for the safe harbors from liability provided by Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts are statements that could be deemed forward-looking. These statements are based on current expectations, estimates, forecasts and projections about the Company’s business and the industry in which the Company operates and the beliefs and assumptions of the Company’s management. Forward-looking statements can be identified by the use of words such as “will,” “may,” “could,” “should,” “would,” “believe,” “depends,” “expect,” “goal,” “anticipate,” “forecast,” “project,” “future,” “intend,” “plan,” “estimate,” “target,” “indicate,” “outlook,” and similar expressions of future intent or the negative of such terms. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, these forward-looking statements are based on management’s current beliefs, expectations and assumptions and are subject to risks and uncertainties. These statements are based on the Company’s current beliefs or expectations and are inherently subject to various risks and uncertainties, including those set forth under the caption “Risk Factors” in the Company’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other periodic reports the Company files with the Securities and Exchange Commission.  Additionally, many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 outbreak and the effects thereof on the Company’s future performance and results of operations. It is not possible to predict or identify all such risks. There may be additional risks that the Company considers immaterial or which are unknown. You should not rely upon forward-looking statements as predictions of future events.  The forward-looking statements included in this press release speak only as of the date hereof and, subject to any continuing obligations under applicable law or any relevant stock exchange rules, we expressly disclaim any obligation to disseminate, after the date of this document, any updates or revisions to any such forward-looking statements to reflect any change in expectations or events, conditions or circumstances on which any such statements are based.

 

Contact:

Philip K. Yachmetz

Teligent, Inc.

(856) 776-4632

www.teligent.com

 

 

EX-101.SCH 4 tlgt-20210415.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 tlgt-20210415_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 tlgt-20210415_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 tm2112973d1_ex99-1img001.jpg GRAPHIC begin 644 tm2112973d1_ex99-1img001.jpg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end XML 8 tm2112973d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000352998 2021-04-15 2021-04-15 iso4217:USD shares iso4217:USD shares 0000352998 false 8-K 2021-04-15 TELIGENT, INC. DE 001-08568 01-0355758 105 Lincoln Avenue Buena NJ 08310 856 697-1441 false false false false Common Stock, par value $0.01 per share TLGT NASDAQ false XML 9 R1.htm IDEA: XBRL DOCUMENT v3.21.1
Cover
Apr. 15, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 15, 2021
Entity File Number 001-08568
Entity Registrant Name TELIGENT, INC.
Entity Central Index Key 0000352998
Entity Tax Identification Number 01-0355758
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 105 Lincoln Avenue
Entity Address, City or Town Buena
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 08310
City Area Code 856
Local Phone Number 697-1441
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol TLGT
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ]"CU('04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " /0H]2FR$.U^\ K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R$ZW4DSJ2\M.&PQ6V-C-V&IK&B?&UDCZ]G.R-F5L#["CI=^? M/H%J$Z3I(K[$+F DA^EN\$V;I EK=B0*$B"9(WJ=RIQH&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" /0H]2\R<^JB<$ E$ & 'AL+W=O00 MWKY'!FRZ-<>TN0B6K?/[TSGBET1_J_2KV7!NR7L22W/7V%B;?O0\$VYXPLRU M2KF$)RNE$V:AJ=>>235G41Z4Q%[@^S=>PH1L#/KYO9D>]%5F8R'Y3!.3)0G3 MNWL>J^U=@S:.-U[$>F/=#6_03]F:S[G]-9UI:'F%2B02+HU0DFB^NFL,Z,Q#ZR08?+SQ$8]CIP0#I]5'],1\\#&;)#!^I^*N([.:NT6N0B*]8%ML7M?V)'P;4<7JABDW^GVSW M?=OM!@DS8U5R" :"1,C])WL_).(TP#\3$!P"@IQ[_Z*<\H%9-NAKM27:]08U M=Y$/-8\&."%=5>96PU,!<78P4F]<]ST+4NZ&%Q["[O=AP9FP8:JO">TT2> ' M])_A'A 4&$&!$>1Z+0R#_#%<&JNA4'\BDJU"LI5+ML](/J@P@^ECR6*7\JH1 MXN&]JT\(1+N :*,J0R"(+H% M3_<2GA>^%FXV0M*F+*G,%*ZS&#]/GL;319-,IJ-K!*Q7@/4N 1M!'36+R41& M_)U\XKLJ-%S)A[]6)[B]Q?)U6V#=7H*U8.]D$@&;6(F0Y99[OIJXHBMFJ]/I M=C \ZI<6YU\".)&ATJG2.5N3S"W,?Z(T&:D,$@IY55%EE6O4'\88Y(D/TTL@ MAU&DN3'-XP5YAG[DBZPFPR6IWW'AL$1(,GSC,L.U>T78;6YAHN1)0W,*_:F$MEY"8),GDP=9,)14N5+>.TW(-H+AUSU4L M0F&%7)//,+VU8'$E#ZY2RU.:/\6]>J;Y50CIX?#]VF^W8,<#>[DOJ]69^N%Z M=61!:?L!;LS_(IL8DP%9'6"-;"U@:?D![L\+86'+HU:$!C\L?R1S'F8PWRJ7 M\QHE-S]AO9U;%;XV26-QQLGW_K5/20JC-1NF4>J3G3KNUPO-(C?[YKMD MJ2KG7IW \],"(RG]/L"]^9@P,GX/-TRN^=F-6HW0=#A_&/Z",95&'UQD]..$ MZ[7+TA,HV(TSD)3)ZM+^SQ. =W+HO]F73?L"K- MSX%+9>%4F5]NX!S/M>L SU=*V6/#'2V+7P8&?P-02P,$% @ #T*/4I^@ M&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)JXI$8 MMD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN6W>2 M_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9WMQD MB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+E)"G M8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64,\$E M#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).IF(M M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5B'_2^FO-C MT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P:?EA6;/C MO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/[I_X3O,\3;,, MJ^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*PG>*3B.T4KS4@ M\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY_U=3_ 102P,$ M% @ #T*/4I>*NQS $P( L !?3T\$MP>:4#M.*2V MBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5*(Y5;&GC3Y?YV MX$G1H2)8%II%R=.B':5_'B4?'D78FYJD6:>IK&HP=MX1PT$G53$WHI"/J:Q8;!E MK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7D(GP&LK\,S4-AB.G8RF2&]B]#V,YU#BG/]3 M(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMRR"9JZJ8IGJ,.>%,. M]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7LN48Y0]02P,$ M% @ #T*/4B0>FZ*M ^ $ !H !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*] M:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8V MP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X! M4$L#!!0 ( ]"CU)ED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-= M+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5 MA4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0 M]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K M'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+* M&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>= M(\G=560C2&2FKW@ALO7L^T%.6X.^D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( ]"CU+S)SZJ M)P0 "40 8 " @0X( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " /0H]2 M99!YDAD! #/ P $P @ %U$@ 6T-O;G1E;G1?5'EP97-= :+GAM;%!+!08 "0 ) #X" "_$P ! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.1 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://igilabs.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2112973d1_8k.htm tlgt-20210415.xsd tlgt-20210415_lab.xml tlgt-20210415_pre.xml tm2112973d1_ex10-1.htm tm2112973d1_ex99-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2112973d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2112973d1_8k.htm" ] }, "labelLink": { "local": [ "tlgt-20210415_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "tlgt-20210415_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "tlgt-20210415.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "tlgt", "nsuri": "http://igilabs.com/20210415", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2112973d1_8k.htm", "contextRef": "From2021-04-15to2021-04-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://igilabs.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2112973d1_8k.htm", "contextRef": "From2021-04-15to2021-04-15", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://igilabs.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 16 0001104659-21-050505-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-050505-xbrl.zip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end